US Patent Issued to EmendoBio on Aug. 4 for "CRISPR compositions and methods for promoting gene editing of ribosomal protein S19 (RPS19) gene" (Israeli Inventors)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,513, issued on Aug. 4, was assigned to EmendoBio Inc. (Wilmington, Del.).

"CRISPR compositions and methods for promoting gene editing of ribosomal protein S19 (RPS19) gene" was invented by David Baram (Tel Aviv, Israel), Lior Izhar (Tel Aviv, Israel), Asael Herman (Ness-Ziona, Israel), Rafi Emmanuel (Ramla, Israel), Michal Golan Mashiach (Ness-Ziona, Israel) and Joseph Georgeson (Rehovot, Israel).

According to the abstract* released by the U.S. Patent & Trademark Office: "Isolated guide RNA (gRNA) molecules comprising CRISPR (crRNA) molecules that target the 19:41869823_T_C mutation of a Ribosomal Protein S19 (RPS19) allele."

The patent was filed on Feb. 4, 2020, under Applicatio...